A share price of VolitionRX Ltd [VNRX] is currently trading at $0.27, up 0.11%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VNRX shares have lost -6.93% over the last week, with a monthly amount drifted -23.60%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
VolitionRX Ltd [AMEX: VNRX] stock has seen the most recent analyst activity on April 08, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $2.50. Previously, The Benchmark Company downgraded its rating to Hold on February 01, 2023. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $8 on March 10, 2021. Maxim Group initiated its recommendation with a Buy and recommended $6 as its price target on May 16, 2018. The Benchmark Company reiterated a Buy rating for this stock on May 14, 2018, and downed its price target to $5. In a note dated September 07, 2016, Rodman & Renshaw reiterated an Buy rating on this stock and revised its target price from $12 to $10.
VolitionRX Ltd experienced fluctuations in its stock price throughout the past year between $0.23 and $0.94. VolitionRX Ltd [AMEX: VNRX] shares were valued at $0.27 at the most recent close of the market.
Analyzing the VNRX fundamentals
Trailing Twelve Months sales for VolitionRX Ltd [AMEX:VNRX] were 1.47M which represents 32.19% growth. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at -11.96%, Pretax Profit Margin comes in at -15.64%, and Net Profit Margin reading is -15.54%. To continue investigating profitability, this company’s Return on Assets is posted at -3.55, Equity is 0.84 and Total Capital is 3.54. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2523 points at the first support level, and at 0.2372 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2807, and for the 2nd resistance point, it is at 0.2940.
Ratios To Look Out For
To put it in perspective, the Current Ratio for VolitionRX Ltd [AMEX:VNRX] is 0.12. As well, the Quick Ratio is 0.12, while the Cash Ratio is 0.02. Considering the valuation of this stock, the price to sales ratio is 22.34.
Transactions by insiders
Recent insider trading involved Reynolds Cameron John, President and CEO, that happened on Nov 17 ’25 when 20000.0 shares were purchased. President and CEO, Reynolds Cameron John completed a deal on Oct 14 ’25 to buy 0.11 million shares. Meanwhile, Director Innes Guy Archibald bought 96153.0 shares on Oct 14 ’25.
